FACCHETTI, GIORGIO
FACCHETTI, GIORGIO
Dipartimento di Scienze Farmaceutiche
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction
2012 G. Facchetti, E. Cesarotti, M. Pellizzoni, D. Zerla, I. Rimoldi
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase
2018 G. Facchetti, I. Rimoldi
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH)
2014 G. Facchetti, D. Zerla, M. Fusè, M. Pellizzoni, C. Castellano, E. Cesarotti, R. Gandolfi, I. Rimoldi
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH)
2014 D. Zerla, G. Facchetti, M. Fusè, M. Pellizzoni, C. Castellano, E. Cesarotti, R. Gandolfi, I. Rimoldi
A new artificial reductase based on the D-Ala-D-Ala/Vancomycin supramolecular interaction and its applications in the enantioselective reduction of cyclic imines
2019 G. Facchetti, I. Rimoldi
A novel series of monofunctional Pt(II) complexes framed on 8-aminoquinoline: synthesis and antiproliferative studies
2019 G. Facchetti, N. Ferri, M. Lupo, I. Rimoldi
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex
2021 G. Facchetti, R. Bucci, M. Fusè, E. Erba, R. Gandolfi, S. Pellegrino, I. Rimoldi
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer
2012 M. Pellizzoni, G. Facchetti, E. Cesarotti, I. Rimoldi, D. Zerla
Amphiphilic Pt(II) complexes for in vivo bioimaging applications
2021 G. Facchetti, A. Aliprandi, I.S. Rimoldi, C. Tortiglione, T. Pecoraro, G. Tommasini, A. Tino, S. Morghera, L. DE COLA
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties
2017 F. Porta, G. Facchetti, N. Ferri, A. Gelain, F. Meneghetti, S. Villa, D. Barlocco, D. Masciocchi, A. Asai, N. Miyoshi, S. Marchianò, B. Kwon, Y. Jin, V. Gandin, C. Marzano, I. Rimoldi
An oxadiazole Pt(II) complex with promising in vivo antitumor activity
2016 F. Porta, G. Facchetti, S. Villa, A. Gelain, F. Meneghetti, D. Barlocco, N. Ferri, C. Marzano, V. Gandin, A. Asai, I. Rimoldi
Anticancer platinum(II) complexes bearing N-heterocycle rings
2019 G. Facchetti, I. Rimoldi
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ
2020 E. Corsini, G. Facchetti, S. Esposito, A. Maddalon, I. Rimoldi, M.S. Christodoulou
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media
2021 G. Facchetti, I. Rimoldi
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands
2020 G. Facchetti, M.S. Christodoulou, E. Binda, M. Fus(`(e)), I.S. Rimoldi
Asymmetric Hydrogenation vs Transfer Hydrogenation in the Reduction of Cyclic Imines
2018 G. Facchetti, R. Bucci, M. Fusè, I.S. Rimoldi
Asymmetric one-pot reaction matching chemical and biocatalytic approaches
2022 G. Coffetti, R. Gandolfi, G. Facchetti, I.S. Rimoldi
Asymmetric reduction of cyclic imines by a new hybrid catalyst based on an iridium-vancomycin system
2019 G. Facchetti, I. Rimoldi
Asymmetric reduction of cyclic imines by a new hybrid catalyst based on an iridium/ Vancomycin system
2020 G. Facchetti, I. Rimoldi
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds
2020 G. Facchetti, M. Christodoulou, L. Barragán Mendoza, F. Cusinato, L. Dalla Via, I. Rimoldi